Symbol
| TMEFF2
| contributors: mct - updated : 20-12-2011
|
HGNC name
| transmembrane protein with EGF-like and two follistatin-like domains 2
|
HGNC id
| 11867
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
by hypermethylation in sporadic colorectal and bladder cancer and in ulcerative colitis associated colorectal carcinoma | tumoral
|  
|  
| --over
|  
|
in androgen-dependent prostate cancer | tumoral
|  
|  
| --low
|  
|
in brain cancers and is negatively correlated with PDGFA expression | tumoral
|  
|  
| --low
|  
|
silencing by methylation in esophageal squamous cell carcinoma | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| methylated SFRP2 and TMEFF2 detected in 94.2 p100, and 71.2 p100 of colorecal cancer (CRC), and methylation testing of fecal DNA may be a simple and promising non-invasive screening method for CRC and precancerous lesions | |
| Therapy target
| immunotherapeutic target for the treatment of prostate cancer |
| |